JHSPH Center for Clinical Trials
14
2
4
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 5/100
7.1%
1 terminated/withdrawn out of 14 trials
88.9%
+2.4% vs industry average
79%
11 trials in Phase 3/4
100%
8 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Early Intervention to Promote Cardiovascular Health of Mothers and Children
Role: lead
Multi-Center Clean Air Randomized Controlled Trial in COPD
Role: lead
Adalimumab vs. Conventional Immunosuppression for Uveitis Trial
Role: lead
Natural Versus Programmed Frozen Embryo Transfer (NatPro)
Role: lead
Escitalopram for Agitation in Alzheimer's Disease
Role: lead
Social Needs App for Oncology Patients Phase II
Role: lead
Dronabinol for Agitation in Dementia Crossover Trial
Role: collaborator
Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial
Role: lead
Losartan Effects on Emphysema Progression
Role: lead
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Role: lead
Multicenter Uveitis Steroid Treatment (MUST) Trial
Role: lead
The Leukotriene Modifier Or Corticosteroid or Corticosteroid-Salmeterol Trial
Role: lead
Study of Asthma and Nasal Steroids
Role: lead
Citalopram for Agitation in Alzheimer's Disease
Role: lead
All 14 trials loaded